Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.348 EUR | -3.02% | -14.09% | -16.07% |
May. 15 | Medigene AG Presents Preclinical Data on Optimal Affinity TCRs Targeting the Neoantigen Mutant KRAS | CI |
May. 14 | Medigene Ag Maintains Earnings Guidance for 2024 | CI |
- Stock Market
- Equities
- MDG1 Stock
- News Medigene AG
- MarketScreener Editorial Features